|
(P821) |
Endothelial α1AMPK activation abolishes aircraft noise-induced cardiovascular oxidative stress and endothelial dysfunction |
| |
|
M. Kvandova, I. Schmal, S. Kalinovic, D. Mihalikova, P. Stamm, A. Daiber, M. Oelze, E. Schulz, T. Münzel, S. Kröller-Schön, T. Jansen (Mainz, Celle) |
|
(P822) |
The mechanosensitive ion channel Piezo1 acts as an anti-inflammatory mediator in the vascular endothelium |
| |
|
B. Fels, C. Vahldieck, E. Hertel, K. Schweim, K. Kusche-Vihrog (Lübeck) |
|
(P823) |
Nuclear endothelial nitric oxide synthase interacts with RNA-binding proteins to modulate endothelial gene expression. |
| |
|
X. Zhou, I. Wittig, M. Siragusa, I. Fleming, für die Studiengruppen: IVS, DZHK (Frankfurt am Main) |
|
(P824) |
Impact of sphingosine-1-phosphate receptor 1 (S1PR1) activation on platelet reactivity |
| |
|
C. Tolksdorf, R. Moj, A. Šimunović, R. Wolf, E. Moritz, G. Jedlitschky, B. H. Rauch (Oldenburg, Greifswald) |
|
(P825) |
Development of ACKR3 agonists as possible treatment for thrombotic events with reduced risk of bleeding. |
| |
|
V. Dicenta, K. Kolb, A.-K. Rohlfing, F. Mohr, S. Laufer, M. Gawaz (Tübingen) |
|
(P826) |
Extracellular ASC specks are released after marathon running and induce proinflammatory effects in endothelial cells in vitro |
| |
|
S. Gaul, A. Kogel, S. Fikenzer, L. Uhlmann, L. Opitz, J. Kneuer, K. G. Häusler, J. Herm, M. Endres, J. Kratzsch, V. F. Schwarz, C. Werner, H. Kalwa, U. Laufs (Leipzig, Würzburg, Berlin, Homburg/Saar) |
|
(P827) |
Normoxische HIF-1α-Stabilisierung an der Gefäßbarriere im Kontext der Atherosklerose |
| |
|
M. Abdi Sarabi, R. Braun-Dullaeus, S. Weinert (Magdeburg) |
|
(P828) |
Modified recombinant adeno-associated viral vectors for endothelial gene editing |
| |
|
T. Ziegler, T. Bozoglu, R. Hinkel, K.-L. Laugwitz, C. Kupatt (München, Göttingen) |